Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Menlo Therapeutics
Menlo Therapeutics
A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
Endpoints
Mon, 04/6/20 - 10:33 am
Menlo Therapeutics
clinical trials
serlopitant
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
Menlo Therapeutics
serlopitant
Peninsula biotech coughs up 40 percent of its value on failed clinical trial
Bizjournals.com
Mon, 10/8/18 - 10:53 pm
clinical trials
IPOs
Menlo Therapeutics
serlopitant
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Forbes
Tue, 01/30/18 - 09:28 am
biotech
NASDAQ
IPOs
ARMO BioSciences
Menlo Therapeutics
Cue Biopharma
In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M
Endpoints
Tue, 01/2/18 - 07:41 pm
biotech
IPOs
PureTech
ARMO BioSciences
Menlo Therapeutics
Solid Biosciences